1Wahner-Roedler DL,Kyle RA.Heavy chain diseases.Best Pract Res Clin Haematol,2005,18:729-746.
2Franklin EC,Lowenstein J,Bigelow B,et al.Heavy chain disease:a new disorder of serum γ-globulins.Am J Med,1964,37:332-350.
3Fine KD,Stone MJ.Alpha-heavy chain disease,mediterranean lymphoma,and immunoproliferative small intestinal disease:a review of clinicopathological features,pathogenesis,and differential diagnosis[J].Am J Gastroenterol,1999,94:1139-1152.
4Halphen M,Najjar T,Jaafoura H,et al.Diagnostic value of upper intestinal fiber endoscopy in primary small intestinal lymphoma:a prospective study by the Tunisian-French Intestinal Lymphoma Group[J].Cancer,1986,58:2140 -2145.
5Agrawal S,Abboudi Z,Matutes E,et al.First report of fludarabine in gamma-heavy chain disease[J].Br J Haematol,1994,88:653-655.
6Khojasteh A,Saalabian MJ,Haghshenass M.Randomized comparison of abdominal irradiation (AI)vs CHOP vs C-MOPP for the treatment of immuno-proliferative small intestinal disease (IPSID)associated lymphoma(AL)[J].Proc Annu Meeting Am Soc Clin Oncology,1983,2:207.
7Ben-Ayed F,Halphen M,Najjar T,et al.Treatment of alpha chain disease:results of a prospective study in 21 Tunisian patients by the Tunisian-French Intestinal Lymphoma Study Group[J].Cancer,1989,63:1251-1256.
8Akbulut H,Soykan I,Yakaryilmaz F,et al.Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease:a Turkish experience[J].Cancer,1997,80:8-14.
9Yanai M,Maeda A,Watanabe N,et al.Successful treatment of mu-heavy chain disease with fludarabine monophosphate:a case report[J].Int J Hemato1,2004,79:174-177.
